Our vision is to be the best nicotine containing products and services group in the world

What we do

Nerudia was established in 2013 to support the rapidly developing nicotine products industry with high quality manufacturing services and to provide scientific support to characterise our customers’ products within a single regulated facility.

Serving the electronic cigarette, NRT, and novel nicotine delivery technology industries, we help our customers bring quality products to the market and at the same time guide them through the regulatory pathways for these novel products.

We are committed to working in partnership with you to deliver value for money products and services. Our service levels, consistency, and drive to constantly improve quality, combined with our innovation and expertise, will help your business grow. Our success will be measured through your successes.

Confidentiality is our top product.

Who we are

Nerudia is a privately owned company founded by David Newns, Chris Lord, and Contraf-Nicotex-Tobacco GmbH.

David and Chris have been involved in the electronic cigarette industry since 2008 when they founded CN Creative and developed the Intellicig brand.

Contraf-Nicotex-Tobacco GmbH are a privately owned company established in 1982, who are the world’s largest provider of pharmaceutical grade nicotine to the pharmaceutical and electronic cigarette industries.


David Newns, Founder

David, who was identified in the ‘Top 50 Young Entrepreneurs to Watch’ in 2009, has been in the Nicotine Products industry since 2008 when he built the CN Creative business with his business partner Chris Lord. Together they co-founded Nerudia in 2013; a business that will be seen as the world's leading authority on nicotine products and next generation products for e-cigarettes.

David has brought his and Chris’s vision and strategy for Nerudia to life. He has achieved this by building a world-class team of scientists and operational and commercial managers. This enables Nerudia to support its customers to achieve their growth plans in this rapidly expanding global market. David’s entrepreneurial spirit is a fundamental driver of the development of the Nerudia brand and businesses which have quickly achieved international status.

Chris Lord, Founder

Chris has twenty years' experience in the medical device industry designing innovative engineering solutions. At CN Creative he was fundamental in developing Nicadex which was awarded a CE mark in December 2012, and became the world’s first medically approved e-cigarette under the e-voke brand in 2015.

As the co-founder of Nerudia, Chris’s development of innovative products and processes brings another unique layer to the Nerudia business. Original in his thinking, he is seen as naturally innovative and skilled at bringing multi-disciplinary teams together.

Tim Byrne,
Deputy Group CEO

Tim first worked with Chris and David at CN Creative, joining them as Chief Finance Officer in 2011 to assist in the company’s growth and prepare for acquisition. After the company was acquired he stayed for a further two years as CFO of Nicoventures Trading UK and Eire.

Having worked at the highest level within major corporations such as Mytravel plc and ITV plc, as well as a number of SMEs, Tim believes that the core of a successful company is its team and leadership. Nerudia’s vision and strategy were what attracted him to re-join forces with another great team assembled by Chris and David.

Andy Gaunt,
Chief Commercial Officer

Andy joined Nerudia in January 2016 as Chief Commercial Officer, bringing a wealth of senior level commercial and selling experience to the role.

For the last 12 years he has run his own consultancy business, working with a huge variety of mainly FMCG clients on project work and in senior commercial roles across many categories. Andy’s experience at Nicoventures, selling into the UK’s major retailers and pharmacies, ideally places Nerudia to help and advise its customers; especially on the approach to listing with major retailers and in particular their quality expectations in this relatively new category.

Andy is responsible for the commercial strategy of Nerudia. His vision is for the company to be recognised globally as the go-to partner for the nicotine products industry, offering an end to end business solution from production through compliance to future innovation.

Rob Burton,
Head of Consultancy & Compliance

Rob, who joined Nerudia in August 2016, is a seasoned Regulatory and Commercial professional having worked in senior positions in the e-cigarette, tobacco and pharmaceutical industries. He most recently spent almost three years with US-based electronic cigarette company White Cloud, where he headed up global Corporate and Regulatory Affairs. Prior to this he spent five years with British American Tobacco, where he was Group Head of Public Health and Scientific Affairs.

Before joining BAT in 2008 Rob spent over 20 years working in the pharmaceutical sector for AstraZeneca and SmithKline Beecham, during which time he held a number of international commercial and scientific roles. An industrial chemist by training, Rob began his career working in the laboratories of Reckitt & Coleman, before moving into sales and marketing functions within Beecham’s UK.

David Jones,
Head of Innovation

David heads up Nerudia’s Innovation Department, which includes Product Designer Tom Sudlow and Formulation Chemist Krystian Jasinski.

He is responsible for managing new innovations from initial concept through prototyping, testing and validation, to design for manufacture. With a Masters in Chemistry with Forensic Science, and having recently submitted his thesis for a PhD, David’s ability to push the boundaries of current technologies combines with the creativity of the design team and expertise in development and testing, ensuring that the team live and breathe Nerudia’s cycle of Efficient Innovation.

Jill Jones,
Head of Production Operations

Jill, who has over 20 years’ experience in the pharmaceutical and chemical industries, joined Nerudia in February 2016 as Head of Operations having spent the past 14 years working for a company that develops and manufactures products for clinical trials. Most recently she spent 10 years as their Operations Manager where her achievements included overseeing the design and coordination with the MHRA of a new GMP manufacturing area, and achieving a successful FDA audit. Jill’s past experience also includes time spent as a Quality Assurance Manager and an R&D Scientist.

Jill’s role at Nerudia is to manage and oversee the effective and efficient production of the full range of products to the highest possible quality standards required by our customers. Her responsibilities include the day to day management of warehousing and logistics, production, planning and purchasing.

Stephen McDonald,
Head of Intellectual Property

Steve joined Nerudia in November 2014 having spent more than 20 years in similar roles with leading multi-national companies including Nokia, Siemens Networks, Texas Instruments, and the Nidec Corporation.

Steve’s day-to-day role is to coordinate and manage the legal activities of Nerudia’s businesses. Having trained as a Patent Attorney he is responsible for harvesting inventions from Nerudia’s Innovation Department and for developing its rapidly growing IP portfolio.

Glenn Ridsdale,
Senior Finance Officer

Glenn is a qualified Chartered Accountant with a wide range of business experience, having worked in companies from Sodexo to ITV to Mytravel.

As Senior Finance Officer Glenn is responsible for the IT and Finance teams at Nerudia. His experience at a very senior level across a number of significant businesses ensures the development of systems in our growing business as quickly as possible and to the highest standards.

Michael Murray,
Head of IT

Michael joined us in 2015 bringing almost 20 years’ experience in Information Technology to Nerudia. He has worked for several multinational organisations in manufacturing, facilities management and IT professional services sectors.

As Head of IT, Michael is responsible for the IT service management of the business which encompasses managing the IT strategy, projects, risk and day to day IT operations. The management of the IT systems that we use as a company is vital in maintaining our GMP status as a licenced pharmaceutical facility.

Darren Sellings,
Head of Engineering

Darren is a Chartered Mechanical Engineer with 28 years’ experience across a number of industry sectors, including 10 years in pharmaceutical and 12 years on top tier COMAH chemical sites. He has held various project engineering and maintenance engineering roles including site mechanical maintenance manager, and been responsible for validation, new product introduction, and in-house production machinery design and build engineering teams.

As Head of Engineering at Nerudia, Darren is responsible for the facility and production maintenance teams, ensuring all equipment is maintained to the required standards and any repairs or breakdowns are actioned promptly and effectively. He also heads up the Project Engineering team, introducing new production equipment and validation of products on new and existing processes.